UNSPSC 85265500: Diagnoses of disorders of glycoprotein metabolism

This classification denotes the group of activities that yields a diagnosis of Disorders of Glycoprotein Metabolism.

Disorders of Glycoprotein Metabolism is listed In The World Health Organization's International Statistical Classification of Diseases and Related Health Problems or Icd-10 as a Three Digit Category under code A00 Icd-10 Also Has The Following Disorders of Glycoprotein Metabolism Children in its Four-Character Category: E770 or Defects In Post-Translational Modification of Lysosomal Enzymes; E771 or Defects In Glycoprotein Degradation; E778 or Other Disorders of Glycoprotein Metabolism; E779 or Disorder of Glycoprotein Metabolism, Unspecified DISORDERS of GLYCOPROTEIN METABOLISM is listed in the Centers For Medicare & Medicaid Services International Classification Of Diseases Clinical Modification (Tenth Revision) (Icd-10-CM) as a Three Digit Category under code E77.

UNSPSC 85265500 Diagnoses of disorders of glycoprotein metabolism is a Class code with minimal alignment to the recent state and local contract opportunities available in the source. The code's nominal scope — clinical laboratory diagnosis of rare metabolic disorders — does not match the three solicitations posted between July and October 2026, which span diagnostic imaging systems procurement, special education contracted services, and temporary health professional staffing across ancillary clinical specialties. The mismatch suggests that this code either carries a misclassification in state and local procurement systems or sees little relevant activity under its stated definition.

The recent opportunities tagged to this code reflect broader health system and education sector purchasing, not metabolic disorder diagnostics specifically. San Mateo Medical Center is procuring an enterprise PACS system for radiology, cardiology, and dental imaging with EPIC integration; Birdville Independent School District is contracting for special education services including audiologists, diagnosticians, and therapists; and Santa Clara Health System is building a qualified vendor pool for temporary staffing in audiology, diagnostic imaging, and therapy services. These solicitations show state and local health systems and school districts sourcing clinical support services and imaging infrastructure, but none directly target glycoprotein metabolism testing or diagnosis. Without representative recent opportunities aligned to the code's stated scope, the code presents no clear procurement signal for business development targeting state and local buyers.